ACACIA RESEARCH CORP
Business
Acacia Research Corporation acquires and operates businesses across intellectual property, energy, industrial, and manufacturing sectors. The company generates value through patent licensing and enforcement, oil and natural gas production via Benchmark Energy, industrial printer manufacturing and consumables, and specialty products via Deflecto. The company also holds a portfolio of life sciences securities and pursues strategic equity positions in public companies.
Summary from 10-K filed 2026-03-12
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 285 | 122 | 125 | 59 | 88 | |
| Cost of revenues - intellectual property operations | 201 | 93 | 53 | 37 | 36 | |
| Sales and marketing expenses - industrial and manufacturing operations | 13 | 7 | 7 | 9 | 2 | |
| General and administrative expenses | 65 | 55 | 44 | 53 | 36 | |
| Total costs and expenses | 279 | 155 | 104 | 99 | 74 | |
| Operating income (loss) | 6 | −33 | 21 | −40 | 15 | |
| Change in fair value of equity securities | 1 | −31 | 31 | −264 | 88 | |
| (Loss) gain on sale of equity securities | −25,000 | 29 | −11 | 125 | 116 | |
| Net realized and unrealized gain (loss) | 1 | −3 | 25 | −96 | 207 | |
| Non-recurring legacy legal expense | 0 | −15 | 0 | — | — | |
| Service provider settlement, net | 16 | 0 | 8 | 13 | −40 | |
| Gain on derivatives - energy operations | 7 | 2 | 1 | — | — | |
| Gain (loss) on foreign currency exchange | 414,000 | −370,000 | 53,000 | −3 | −89,000 | |
| Interest expense | −9 | −6 | −2 | −6 | −8 | |
| Interest income | 11 | 18 | — | — | — | |
| Other expense, net | −2 | −677,000 | 14 | 5 | 501,000 | |
| Total other income (expense) | 25 | −5 | 46 | −87 | 160 | |
| Income (loss) before income taxes | 31 | −38 | 67 | −127 | 175 | |
| Income tax (expense) benefit | −7 | 3 | 2 | 16 | −24 | |
| Net income (loss) including noncontrolling interests in subsidiaries | 24 | −35 | 69 | −111 | 150 | |
| Net income attributable to noncontrolling interests in subsidiaries | −3 | −1 | −2 | −14 | −1 | |
| Net income (loss) attributable to Acacia Research Corporation | 22 | −36 | 67 | −125 | 149 | |
| Net income (loss) attributable to common stockholders - Basic | 22 | −36 | 55 | −133 | 119 | |
| Weighted average number of shares outstanding - Basic | 96 | 99 | 75 | 42 | 49 | |
| Basic net income (loss) per common share (in usd per share) | 0.23 | −0.36 | 0.73 | −3.13 | 2.43 | |
| Net income (loss) attributable to common stockholders - Diluted | 22 | −36 | 53 | −133 | 188 | |
| Weighted average number of shares outstanding - Diluted | 97 | 99 | 92 | 42 | 98 | |
| Diluted net income (loss) per common share (in usd per share) | 0.22 | −0.36 | 0.58 | −3.13 | 1.91 | |
| Foreign currency translation | 2 | −1 | 0 | — | — | |
| Other comprehensive income | 2 | −1 | 0 | — | — | |
| Total comprehensive income (loss) | 26 | −36 | 69 | — | — | |
| Comprehensive income attributable to noncontrolling interests | −3 | −1 | −2 | — | — | |
| Comprehensive income (loss) attributable to Acacia Research Corporation | 24 | −37 | 67 | — | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 307 | 274 | 340 | 288 | 309 | |
| Equity securities | 18 | 23 | 63 | 62 | 362 | |
| Equity securities without readily determinable fair value | 6 | 6 | 6 | 6 | 6 | |
| Equity method investments | 31 | 31 | 31 | 31 | 31 | |
| Loans receivable | 15 | 0 | — | — | — | |
| Accounts receivable, net | 26 | 27 | 81 | 8 | 10 | |
| Inventories | 27 | 27 | 11 | 14 | 9 | |
| Prepaid expenses and other current assets | 21 | 32 | 23 | 19 | 5 | |
| Total current assets | 450 | 420 | 555 | 428 | 731 | |
| Property, plant and equipment, net | 21 | 24 | 2 | 4 | 4 | |
| Oil and natural gas properties, net | 191 | 192 | 25 | 0 | — | |
| Goodwill | 26 | 29 | 9 | 8 | 7 | |
| Net Book Value | 48 | 55 | 34 | 37 | 49 | |
| Operating lease, right-of-use assets | 12 | 9 | 2 | 2 | 2 | |
| Deferred income tax assets, net | 15 | 20 | 3 | 0 | — | |
| Other non-current assets | 9 | 6 | 4 | 5 | 5 | |
| Total assets | 771 | 756 | 634 | 483 | 799 | |
| Accounts payable | 13 | 12 | 3 | 6 | 5 | |
| Accrued expenses and other current liabilities | 20 | 21 | 8 | 14 | 6 | |
| Accrued compensation | 7 | 6 | 4 | 5 | 4 | |
| Current asset retirement obligation | 2 | 2 | 0 | — | — | |
| Royalties and contingent legal fees payable | 7 | 5 | 11 | 699,000 | 2 | |
| Deferred revenue | 945,000 | 1 | 977,000 | 1 | 1 | |
| Current portion of long-term debt | 0 | 2 | — | — | — | |
| Total current liabilities | 49 | 50 | 28 | 87 | 200 | |
| Asset retirement obligation | 33 | 31 | 294,000 | — | — | |
| Long-term lease liabilities | 8 | 7 | 2 | 2 | 2 | |
| Deferred income tax liabilities, net | 2 | 3 | 0 | 742,000 | 19 | |
| Benchmark revolving credit facility | 60 | 67 | 11 | 0 | — | |
| Deflecto facility | 33 | 45 | 0 | — | — | |
| Other long-term liabilities | 3 | 2 | 4 | 2 | 6 | |
| Total liabilities | 187 | 204 | 44 | 194 | 354 | |
| Commitments and contingencies (Note 16) | — | — | — | — | — | |
| Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value $0.001 per share; 300,000,000 shares authorized; 96,475,469 and 96,048,999 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 96,000 | 96,000 | 100,000 | 43,000 | 49,000 | |
| Treasury stock, at cost, 20,542,064 shares as of December 31, 2025 and 2024, respectively | −119 | −119 | −98 | −98 | −47 | |
| Accumulated other comprehensive income (loss) | 670,000 | −1 | 0 | — | — | |
| Additional paid-in capital | 915 | 910 | 906 | 663 | 648 | |
| Accumulated deficit | −254 | −276 | −240 | −307 | −182 | |
| Total Acacia Research Corporation stockholders' equity | 543 | 515 | 568 | 258 | 419 | |
| Noncontrolling interests | 41 | 38 | 21 | 11 | 11 | |
| Total stockholders' equity | 584 | 553 | 590 | 269 | 430 | |
| Total liabilities and stockholders' equity | 771 | 756 | 634 | 483 | 799 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation, depletion and amortization | 43 | 34 | 15 | 14 | 11 | |
| Accretion of asset retirement obligation | 2 | 986,000 | 0 | — | — | |
| Loss on disposal of assets | 169,000 | 0 | — | — | — | |
| Compensation expense for share-based awards | 6 | 5 | 3 | 4 | 2 | |
| (Gain) loss on foreign currency exchange | −414,000 | 370,000 | −53,000 | 3 | 89,000 | |
| Change in fair value of equity securities | −1 | 31 | −31 | 264 | −88 | |
| Loss (gain) on sale of equity securities | 25,000 | −29 | 11 | −125 | −116 | |
| Unrealized (gain) loss on derivatives | −4 | 610,000 | −781,000 | 0 | 0 | |
| Deferred income taxes | 5 | −6 | −4 | −18 | 16 | |
| Accounts receivable | 664,000 | 69 | −70 | 998,000 | −747,000 | |
| Inventories | 212,000 | 1 | 3 | −5 | 2 | |
| Prepaid expenses and other assets | −5 | −9 | −820,000 | −6 | −78,000 | |
| Accounts payable and accrued expenses | 3 | −8 | −5 | −136,000 | 760,000 | |
| Royalties and contingent legal fees payable | 1 | −5 | 751,000 | −2 | 301,000 | |
| Deferred revenue | 98,000 | 497,000 | −337,000 | 100,000 | −246,000 | |
| Net cash provided by operating activities | 75 | 50 | −23 | −37 | 13 | |
| Acquisition, net of cash acquired and working capital adjustments (Note 3) | 1 | −88 | −9 | 0 | −33 | |
| Patent acquisition | 0 | −14 | −6 | −5 | −21 | |
| Proceeds from sale of floor mat assets | 3 | 0 | — | 0 | 4 | |
| Purchases of equity securities | −25 | −20 | −13 | −112 | −67 | |
| Sales of equity securities | 31 | 58 | 32 | 274 | 155 | |
| Purchases of loans receivable | −15 | 0 | — | — | — | |
| Purchases of property and equipment | −3 | 0 | — | — | — | |
| Net additions to oil and gas properties | −14 | −149 | — | — | — | |
| Net cash used in investing activities | −21 | −213 | 16 | 184 | 36 | |
| Repurchase of common stock | 0 | −20 | 0 | −51 | −4 | |
| Contributions from noncontrolling interest | 0 | 15 | 0 | — | — | |
| Borrowings on the Benchmark revolving credit facility | 5 | 86 | 0 | — | — | |
| Paydown of Benchmark revolving credit facility | −12 | −30 | −8 | 0 | — | |
| Borrowings on the Deflecto Facility | 0 | 47 | 0 | — | — | |
| Paydown of Deflecto Facility | 15 | 0 | −60 | −120 | −50 | |
| Taxes paid related to net share settlement of share-based awards | −675,000 | −1 | −614,000 | −2 | 0 | |
| Proceeds from exercise of stock options | 30,000 | 223,000 | 235,000 | 0 | 202,000 | |
| Net cash (used in) provided by financing activities | −23 | 98 | 59 | −166 | 60 | |
| Effect of exchange rates on cash and cash equivalents | 1 | −926,000 | 1,000 | −3 | 0 | |
| Increase (decrease) in cash and cash equivalents | 33 | −66 | 52 | −22 | 109 | |
| Interest paid | 8 | 5 | — | — | — | |
| Income taxes paid, net | 2 | 1 | 831,000 | 384,000 | 25,000 | |
| Operating lease right-of-use assets obtained in exchange for lease liabilities | 2 | 0 | — | — | — | |
| Derecognition of operating lease right-of-use assets upon lease termination | −608,000 | 0 | — | — | — | |
| Derecognition of operating lease liabilities upon lease termination | −632,000 | 0 | — | — | — | |
| Patent acquisition of prepaid option | 15 | 0 | — | 0 | 4 |
Filings
Material Events
Insiders
Institutional Holders
Holdings (13F)
Portfolio as of 2023-09-30 · 4 positions
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $14.11M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| NEWPARK RES INC | — | 902.2K | $6.23M | 44.2% |
| COMTECH TELECOMMUNICATIONS C | — | 480.8K | $4.21M | 29.8% |
| ZIMVIE INC | — | 323.3K | $3.04M | 21.6% |
| THERMON GROUP HLDGS INC | — | 23.0K | $631.0K | 4.5% |
Frequently asked questions
What is ACACIA RESEARCH CORP's CIK number?
ACACIA RESEARCH CORP's SEC CIK number is 0000934549 (934549). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find ACACIA RESEARCH CORP's SEC filings?
All of ACACIA RESEARCH CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did ACACIA RESEARCH CORP last report earnings?
ACACIA RESEARCH CORP (ACTG) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000934549-26-000020). This is ACACIA RESEARCH CORP's most recent earnings filing of record — not a forecast of its next earnings date.
What is ACACIA RESEARCH CORP's most recent earnings 8-K?
ACACIA RESEARCH CORP's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0000934549-26-000020. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View ACACIA RESEARCH CORP's latest earnings 8-K →
Look up any company's CIK number →